FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Johnson Bankole A.
  2. Issuer Name and Ticker or Trading Symbol
ADIAL PHARMACEUTICALS, INC. [ADIL]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Medical Officer
(Last)
(First)
(Middle)
1001 RESEARCH PARK BLVD., SUITE 100
3. Date of Earliest Transaction (Month/Day/Year)
03/28/2019
(Street)

CHARLOTTESVILLE, VA 22911
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/28/2019   P   40,000 A $ 3.1452 314,768 D  
Common Stock 03/29/2019   P   30,000 A $ 3.4718 344,768 D  
Common Stock 03/29/2019   P   2,500 A $ 3.4676 347,268 D  
Common Stock 03/29/2019   P   600 A $ 3.2967 347,868 D  
Common Stock               40,463 I Medico-Trans Company, LLC (1)
Common Stock               848,336 I En Fideicomiso De Mi Vida 11/23/2010 (Trust) (2)
Common Stock               93,000 I En Fidecomiso de Todos Mis Suenos Grantor Retained Annuity Trust dated June 27, 2017 (2)
Common Stock               22,320 I En Fideicomiso De Mis Suenos 11/23/2010 (Trust) (2)
Common Stock               10,000 I De Mi Amor 11/23/2010 (Trust) (2)
Common Stock               4,650 I Efunbowale Johnson (3)
Common Stock               1,395 I Ade Johnson (3)
Common Stock               1,395 I Lola Johnson (3)
Common Stock               930 I Lina Tiouririne (3)
Common Stock               930 I Aida Tiouririne (3)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $ 5.7               (4) 06/30/2027 Common Stock 5,580   5,580 D  
Stock Option $ 3.01               (5) 03/23/2029 Common Stock 250,000   250,000 D  
Warrant to purchase common stock $ 7.63             10/10/2017 12/31/2031 Common Stock 3,275   3,275 D  
Warrant to purchase common stock $ 6.25             07/31/2018 07/31/2023 Common Stock 189,714   189,714 D  
Warrant to purchase common stock $ 5             11/12/2018 07/31/2023 Common Stock 17,600   17,600 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Johnson Bankole A.
1001 RESEARCH PARK BLVD., SUITE 100
CHARLOTTESVILLE, VA 22911
    X   Chief Medical Officer  

Signatures

 /s/ Bankole Johnson   04/01/2019
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Medico-Trans Company, LLC is controlled by Bankole Johnson.
(2) Dr. Johnson is the trustee of each of these trusts.
(3) Dr. Johnson has a voting proxy on this person's behalf that entitles him to vote these shares.
(4) Options to buy 3,100 shares are currently exercisable with the remaining options to buy 2,480 shares vesting 1/36th (155 shares) on the first day of each month over the remaining 16 months.
(5) Options to buy 250,000 shares vest pro rata on a monthly basis over 36 months commencing March 24, 2019.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.